The MDM2 RING-finger domain is required to promote p53 nuclear export

Nature Cell Biology

Volumn 2, Issue 9, 2000, Pages 569-573

  Geyer, Rory K ^a   Yu, Zhong K ^a   Maki, Carl G ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; HUMAN; PROTEIN P53; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; UBIQUITINS; ZINC FINGERS;

EID: 0034282220     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35023507     Document Type: Article

References (27)

1. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
2. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by MDM2. Nature 387, 299-303 (1997).
3. Kudo, N. et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540-547 (1998).
4. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell Biol. 18, 7288-7293 (1998).
5. Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660-1672 (1999).
6. Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T. & Levine, A. J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via 3 pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564 (1998).
7. Chen, J., Marechal, V. & Levine, A. J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell Biol. 13, 4107-4114 (1993).
8. Unger, T., Mietz, J. A., Scheffner, M., Yee, C. L. & Howley, P. M. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell Biol. 13, 5186-5194 (1993).
9. Ellenbaas, B., Dobblestein, M., Roth, J., Shenk, T. & Levine, A. J. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med. 2, 439-451 (1996).
10. Honda, R., Tanaka, H. & Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27 (1997).
11. Taminura, S. et al. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447, 5-9 (1999).
12. Kubbutat, M. H., Ludwig, R. L., Levine, A. J. & Vousden, K. H. Analysis of the degradation function of Mdm2. Cell Growth Diff. 10, 87-92 (1999).
13. Maki, C. G., Huibregtse, J. M. & Howley, P. M. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654 (1996).
14. Olivier, M., Bautista, S., Valles, H. & Theillet, C. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53. Mol. Carcinogenesis 23, 1-12 (1998).
15. Kamura, T. et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657-661 (1999).
16. Skowyra, D. et al. Reconstitution of G1 cyclin ubiquitination with complexes containing SCF grr and Rbx1. Science 284, 662-665 (1999).
17. Gostissa, M. et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462-6471 (1999).
18. Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455-6461 (1999).
19. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J. C. & Levine, A. J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14, 7414-7420 1994.
20. Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and MDM2. Proc. Natl Acad. Sci. USA 95, 8292-8297 (1998).
21. Honda, R. & Yasuda, H. Association of p19 ARF with MDM2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J. 18, 22-27 (1999).
22. Tao, W. & Levine, A. J. p19 (ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of MDM2. Proc. Natl Acad. Sci. USA 96, 6937-6941 (1999).
23. Zhang, Y. & Xiong, Y. Mutations in human ARF exon two disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579-591 (1999).
24. Weber, J. D., Taylor, J. D., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20-26 (1999).
25. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
26. Sakaguchi, K. et al. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-10124 (1997).
27. Unger, T., Mietz, J. A., Scheffner, M., Yee, C. L. & Howley, P. M. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell Biol. 13, 5186-5194 (1993).